McCormick Consolidates Two Tesla Chancery Cases
Two cases challenging Elon Musk’s investments in AI projects were consolidated while another shareholder suit will move toward a separate trial.How a Second Trump Presidency Could Shape IP
From leadership changes at the U.S. Patent and Trademark Office to shifts in biopharmaceutical patent policy to regulation of rapidly evolving fields like artificial intelligence, here’s what the IP community can expect from a second Trump presidency.Davis Polk Lands Spirit Chapter 11 Amid Bankruptcy Resurgence
After a slower Q3, the rate of large corporate bankruptcies picked up in October.Companies' Dirty Little Secret: Those Privacy Opt-Out Requests Usually Aren't Honored
“Ignoring privacy requests in states where they are legally obligatory creates a huge legal risk. Most companies that do so usually don't have evil intentions but haven't properly configured their consent-management tools," said Jules Polonetsky, CEO of the Future of Privacy Forum.Medtronic in the Crosshairs: 3 Suits Claim IP and Employee Poaching
Medical device giant Medtronic was hit with three lawsuits in the District of Delaware on Nov. 12—two by the previous employer of former Medtronic employees, and one by a doctor who claims the company stole her product design.Portal Crypto Exchange Faces Delaware Investor Class Action
“The allegations in the complaint are about investors being bullied into signing these conversions and being lied to about the use of this money,” said Eric Rosen, a partner at Dynamis.FTX Estate Seeks to Recoup $1.76B From Binance, Plus Exec 'Piggy Bank' Payouts
FTX and its affiliates, represented in the bankruptcy court by Sullivan & Cromwell and Landis, Rath & Cobb, have filed a total of 36 adversary actions since Oct. 28, 25 of which were filed on Nov. 8.Trulia 2.0? The Case for a 'Plainly Beneficial' Standard
Today, a new species of litigation—which we call “foot fault litigation”—is presenting the same core problem as the pre-Trulia disclosure settlements and warrants a similar judicial solution.Wilson Sonsini Knocks Out Claims Against Inhibrx Biosciences in Trade Secrets Verdict
"The most important thing about the win is it lets scientists who are really dedicated to trying to improve the lives of cancer patients to get back to focusing on that," said Luis Li, a Wilson Sonsini attorney who served as lead trial counsel for Inhibrx.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250